Copyright ï›™ 2002 Genetics Society America



                      Protein Phosphatase Type 1 Regulates Ion Homeostasis
                                    Saccharomyces cerevisiae

                                    Tara Williams-Hart, Xiaolin Wu Kelly Tatchell1
    Department Biochemistry Molecular Biology, Louisiana State University Health Sciences Center, Shreveport, Louisiana 71130
                                                      Manuscript received September 18, 2001
                                                      Accepted publication January 25, 2002


                                                              ABSTRACT
               Protein phosphatase type 1 (PP1) encoded essential gene GLC7 Saccharomyces cerevisiae. glc7-
             109 (K259A, R260A) dominant, hyperglycogen defect recessive, ion drug sensitivity.
             Surprisingly, hyperglycogen phenotype partially retained null mutants GAC1, GIP2, PIG1,
             encode potential glycogen-targeting subunits Glc7. R260A substitution GLC7 responsible
             dominant recessive traits glc7-109. mutation residue, glc7-R260P, confers
             salt sensitivity, indicating glycogen salt traits glc7-109 defects distinct
             physiological pathways. glc7-109 mutant sensitive cations, aminoglycosides, alkaline pH              exhibits increased rates l-leucine 3,3â¬˜-dihexyloxacarbocyanine iodide uptake, resistant              molar concentrations sorbitol KCl, indicating normal osmoregulation. KCl suppresses              ion drug sensitivities glc7-109 mutant. CsCl sensitivity mutant suppressed              recessive mutations PMA1, encodes essential plasma membrane Hâ«¹ATPase.               results indicate Glc7 regulates ion homeostasis controlling ion transport plasma membrane
             potential, new role Glc7 budding yeast.



P     ROTEIN phosphatase type 1 (PP1) charac-
     terized serine/threonine protein phosphatase (Shen-
olikar Nairn 1991; Shenolikar 1994) roles
                                                                             1995; Baker et al. 1997; Bloecher Tatchell 1999;
                                                                             Sassoon et al. 1999), glucose repression (Tu Carl-
                                                                             son 1995; Baker et al. 1997), glycogen metabolism wide range physiological processes. Multiple iso-                    (Feng et al. 1991; Cannon et al. 1994; Baker et al. 1997;
forms mammalian PP1 implicated cell                          Ramaswamy et al. 1998), vacuole fusion (Peters et al.
cycle regulation (reviewed Shenolikar 1994), facili-                      1999) cell wall integrity (Andrews Stark
tation CREB gene transcription, activation gly-                    2000). mammalian PP1 linked cogen synthesis lipid metabolism (reviewed                            ion transport, previous work charac-
Shenolikar 1994; Villafranca et al. 1996), neuro-                            terizing role Glc7 regulator ion homeostasis
transmission (Browning et al. 1985; Mulkey et al. 1994;                      S. cerevisiae.
Allen et al. 1997; Greengard et al. 1998; MacMillan                             maintenance ion homeostasis essential
et al. 1999; Smith et al. 1999), control Ca2â«¹ trans-                  highly regulated process involving numerous trans-
port cardiac sarcoplasmic reticulum (reviewed                          port systems. transport systems involved Shenolikar Nairn 1991), regulation                            regulating cell volume, maintaining intracellular pH
translational initiation  et al. 1998; Novoa et al.                       ionic composition, extracting concentrating
2001). widely accepted substrate specificity                   environmental metabolic fuels, extruding toxic sub-
dictated targeting subunits facilitate associa-                  stances, generating essential ionic gradients  
tion catalytic subunit PP1 (PP1c)                         viewed Andre 1995; van der Rest et al. 1995). specific substrates (Egloff et al. 1997).                                    maintenance transport systems fungi    Saccharomyces cerevisiae, single, essential gene                   plants driven plasma membrane Hâ«¹ATPase,
GLC7 encodes PP1c case mammalian                            encoded essential gene, PMA1 S.
PP1, Glc7 implicated wide range pro-
                                                                             cerevisiae. Pma1 protein Hâ«¹ pump responsi-
cesses based primarily diversity GLC7 mutant
                                                                             ble regulation intracellular pH, ion transport,
phenotypes. GLC7 mutants described                                                                              membrane electrochemical potential (Serrano
defects meiosis sporulation (Tu et al. 1996; Baker
                                                                             1983a; Chang Slayman 1991; Serrano et al. 1991,
et al. 1997; Ramaswamy et al. 1998; Bailis Roeder
                                                                             1992). Evidence suggests Pma1 transcrip-
2000), mitosis (Hisamoto et al. 1995; MacKelvie et al.
                                                                             tionally post-translationally regulated. Transcription
                                                                             Pma1 influenced various transcription factors
  1
                                                                             stimulated glucose metabolism, ammonium
    Corresponding author: Department Biochemistry Molecular
Biology, Louisiana State University Health Sciences Center, 1501 Kings       starvation, cell growth, cell wall integrity (Capieaux
Highway, Shreveport, LA 71130. E-mail: ktatch@lsuhsc.edu                     et al. 1989; Rao Slayman 1993; Garcia-Arranz et

Genetics 160: 1423â€“1437 (April 2002)
 1424                                         T. Williams-Hart, X. Wu K. Tatchell

al. 1994; Ozer et al. 1998).  mRNA                 (0.67  yeast nitrogen base, 2  glucose, appropriate
protein levels Pma1 change significantly dur-            0.01â€“0.05  amino acids). Plate media contained 2  agar.
                                                                      Assays ion tolerance performed liquid growth
ing activation glucose, suggesting case            assays spot dilution tests agar media. Liquid growth
post-translational modulation ATPase activity            assays performed diluting stationary phase cultures primary mechanism Pma1 regulation (Eraso et                4 â«» 107 cells/ml media described  Cell concen-
al. 1987).                                                         trations determined measuring optical density 600
  activity Pma1 changes response extracellu-          nm (OD600) microscopic cell counting using stan-
lar glucose (Portillo et al. 1991; Garcia-Arranz et al.            dard hemacytometer. Cultures incubated specified
                                                                   media 1â€“3 hr. Spot dilution tests spotting
1994; van der Rest et al. 1995) Pma1 highly                 serial 10-fold dilutions 1 â«» 108 cells/ml strain
phosphorylated multiple serine threonine resi-              YPD plates, synthetic media, YPD supplemented dues vivo (Kolarov et al. 1988; Bertorello et al.               various concentrations salts drugs. Growth strains
1991; Chang Slayman 1991; Serrano et al. 1991).                pH 3, 5, 8.5 tested liquid YPD medium dimensional phosphopeptide gel analysis Pma1                adjusted 10 n KOH 1 m HCl buffered 100
                                                                   mm potassium phosphate 50 mm succinate, respectively. temperature-sensitive secretion (sec) mutants 
                                                                   Medium containing 0.2 mm KCl consists synthetic medium
vealed phosphorylation plasma membrane-spe-                containing 0.5  ammonium sulfate, 2  glucose, 8 mm ammo-
cific sites associated increased ATPase activity           nium phosphate, 17 mm NaCl, 2 mm MgSO4, 0.2 mm CaCl2, growth glucose (Holcomb et al. 1988; Chang               0.2 mm KCl, plus amino acids, vitamins, trace elements Slayman 1991). glucose starvation, dephos-                described (Guthrie Fink 1991). 3,3â¬˜-Dihexyloxacarbo-
phorylation occurs concomitantly decrease enzy-          cyanine iodide [DiOC6(3)] fluorescence assayed flow
                                                                   cytometery described (Madrid et al. 1998). assay strains
matic activity rapidly reversed addition       0.4 m KCl, strains incubated overnight YPD glucose (Chang Slayman 1991; Estrada et al.                 diluted YPD containing 0.4 m KCl incubated 4 hr
1996). results suggest reversible, site-specific        30â¬š prior flow cytometry analysis.
phosphorylation adjusts ATPase activity protein               General methods: Escherichia coli strains DH5â?£Fâ¬˜, XL1-Blue,
stability (Hasper et al. 1999; Gong Chang 2001)                HB101 used cloning propagation plas- response glucose.                                            mids. Diploid cells induced sporulate YPA (2 
                                                                   potassium acetate, 2  peptone, 1  yeast extract) agar media.
  work motivated observation glc7-            Yeast transformations performed lithium acetate
109, 20 charged alanine-scanning alleles,                method described (Gietz et al. 1992). Qualitative glycogen
uniquely confers NaCl-sensitive phenotype (Baker et              accumulation measurements performed described
al. 1997). Defects ion homeostasis pre-               (Chester 1968). Quantitative glycogen accumulation mea-
viously noted null mutants genes encoding               surements performed described (Wu Tatchell
                                                                   2001). Isolation plasmid yeast DNA genomic DNA phosphatases calcineurin/PP2B (Nakamura et al. 1993;
                                                                   performed variation â€œsmash grabâ€? protocols
Breuder et al. 1994; Mendoza et al. 1994; Farcasanu                Hoffman (Hoffman Winston 1987) described et al. 1995) Ppz1 (Posas et al. 1995)              Ausubel et al. (1989). DNA sequence determined using
mutants GLC7. glc7-109 mutants                T7 Sequenase Version 2.0 kit (Amersham, Life Sciences) sensitive cations, alkaline pH, aminoglycoside          according manufacturerâ€™s instructions.
antibiotics. defects partially ameliorated               Plasmid construction: Plasmids used study listed
                                                                   Table 2. Plasmid p1407-1 genomic library clone exogenous Kâ«¹ mutations PMA1. mutant                   CEN4 URA3 vector, YCp50, contains PMA1 460-
exhibits increased rate uptake fluorescent            bp open reading frame, YGL007. analyze previously
dye DiOC6(3) amino acid l-leucine.                described alanine-scanning allele, glc7-109 (Baker et al. 1997), results suggest Glc7 plays role cellular       genomic integration glc7-109 (K259A, R260A) mutation
response salt stress, possibly regulating ion trans-         performed described (Venturi et al. 2000) using plas-
port membrane potential.                                        mid pTW2. Plasmid pXZ03  gift James Haber) contains
                                                                   HA epitope-tagged PMA1 gene. create K259A,
                                                                   R260A, R260P mutations GLC7, site-directed mutagene-
                                                                   sis carried described (Wu Tatchell 2001)
               MATERIALS METHODS                               using unique oligonucleotide primers. Plasmid pWu361    Yeast strains media: yeast strains used study   constructed using oligonucleotide primer K259Aâ«¹ (5â¬˜-GGTTA listed Table 1. strains used study       TGAATTCTTTAGTGCCAGACAATTGGTGACA-3â¬˜) KT1849 congenic strain KT1112 (MATa ura3-52 leu2            complementary primer K259Aâ«º (5â¬˜-TGTCACCAATTGTCTC
his3; Stuart et al. 1994). trk1::KanMX gip2::KanMX         GGACTAAAGAATTCATAACC-3â¬˜). Plasmid pWu363 
(Research Genetics, Huntsville, AL) cnb1::LEU2 (Cyert          structed using oligonucleotide primer R260Aâ«¹ (5â¬˜-GAATTCT Thorner 1992) mutations introduced               TTAGTAAAGCCCAATTGGTGACACTT-3â¬˜) comple-
KT1112 background seven serial backcrosses. growth          mentary primer R260Aâ«º (5â¬˜-AAGTGTCACCAATTGGGCTT
phenotypes shown study required media contained       TACTAAAGAATTC-3â¬˜). Plasmid pWu365 constructed 
Difco (Detroit) peptone, yeast extract, agar. study,   ing oligonucleotide primer R260Pâ«¹ (5â¬˜-GAATTCTTTAGT
media constituents manufactured Angus Buffers         AAACCGCAATTGGTGACACTT-3â¬˜) complementary Biochemicals impaired growth glc7-109 sup-          primer R260Pâ«º (5â¬˜-AAGTGTCACCAATTGCGGTTTACTAAA
pressor mutants salt antibiotic media. Yeast strains        GAATTC-3â¬˜). underlined nucleotide residues represent routinely incubated 24â¬š 30â¬š YPD (1  yeast     differences complementary strands R260A
extract, 2  Bacto-peptone, 2  dextrose) synthetic media         R260P oligonucleotide primers.
                                                  Glc7-Dependent Ion Transport                                                  1425

                                                             TABLE 1
                                                           Yeast strains

         Strain                                       Genotype                                              Source
         KT1112       MATa his3 leu2 ura3-52                                                        Stuart et al. (1994)
         KT1596       MATâ?£ his3 leu2 ura3-52 glc7-109                                               Venturi et al. (2000)
         KT1935       MATa his3 leu2 trp1 ura3-52 glc7-109                                          study
         KT1937       MATa his3 leu2 trp1 ura3-52                                                   study
         KT1939       MATa his3 leu2 trp1 ura3-52 gac1::LEU2 pig1::URA3                             study
         KT1943       MATa/â?£ his3/his3 leu2/leu2 trp1/trp1 ura3-52/ura3-52                          study
         KT1944       MATa/â?£ his3/his3 leu2/leu2 trp1/trp1 ura3-52/ura3-52 GLC7/glc7-109            study
         KT1945       MATa/â?£ his3/his3 leu2/leu2 trp1/trp1 ura3-52/ura3-52 glc7-109/glc7-109        study
         KT1849       MATa his3 ura3-52 leu1                                                        study
         KT1850       MATâ?£ his3 ura3-52 glc7-109 pma1-s4                                            study
         TW25         MATa his3 leu2 ura3-52 glc7-109                                               study
         TW30         MATa his3 leu2 ura3-52 pma1-s1 glc7-109                                       study
         TW31         MATa his3 leu2 ura3-52 pma1-s2 glc7-109                                       study
         TW33         MATa his3 leu2 ura3-52 pma1-s3 glc7-109                                       study
         TW38         MATâ?£ his3 leu2 ura3-52 pma1-s4 glc7-109                                       study
         TW43         MATâ?£ his3 leu2 ura3-52 pma1-s5 glc7-109                                       study
         TW45         MATâ?£ his3 leu2 ura3-52 pma1-s6 glc7-109                                       study
         TW61         MATâ?£ his3 leu2 ura3-52 pma1-s1 glc7-109                                       study
         TW62         MATa his3 leu2 ura3-52 pma1-s1                                                study
         TW64         MATâ?£ his3 leu2 ura3-52 pma1-s2 glc7-109                                       study
         TW65         MATa his3 leu2 ura3-52 pma1-s2                                                study
         TW68         MATâ?£ his3 leu2 ura 3-52 pma1-s3 glc7-109                                      study
         TW69         MATa his3 leu2 ura3-52 pma1-s3                                                study
         TW71         MATa his3 leu2 ura3-52 pma1-s4 glc7-109                                       study
         TW72         MATa his3 leu2 ura3-52 pma1-s4                                                study
         TW75         MATa his3 leu2 ura3-52 pma1-s5 glc7-109                                       study
         TW76         MATa his3 leu2 ura3-52 pma1-s5                                                study
         TW79         MATa his3 leu2 ura3-52 pma1-s6 glc7-109                                       study
         TW80         MATa his3 leu2 ura3-52 pma1-s6                                                study
         TW82         MATa his3 leu2 ura3-52 cnb1::LEU2                                             study
         TW83         MATâ?£ his3 leu2 ura3-52 cnb1::LEU2                                             study
         TW90         MATâ?£ his3 leu2 ura3-52 cnb1::LEU2 glc7-109                                    study
         TW272        MATâ?£ his3 leu2 ura3 trk1::KanMX                                               study
         TW321        MATâ?£ his3 leu2 ura3-52 trp1 gip2::KanMX glc7-109                              study
         WU318        MATa his3 leu2 ura3-52 trp1 glc7::LEU2, pNC160-HA-glc7-R260A                  study
         WU320        MATa his3 leu2 ura3-52 trp1 glc7::LEU2, pNC160-HA-glc7-R260P                  study
         WU322        MATa his3 leu2 ura3-52 trp1 glc7::LEU2, pNC160-HA-glc7-109                    study
         WU341        MATa his3 leu2 ura3-52 trp1 glc7::LEU2, pNC160-HA-glc7-K259A                  study




   Isolation characterization glc7-109 revertants:     forming tetrad analysis glc7-109 diploid strains heteroallelic
independent cultures glc7-109 strains (KT1596 TW25)          different suppressors. basis complementa- grown YPD 24â¬š 3 â«» 107 cells/ml, plated 2 â«»         tion genetic linkage analysis, suppressors 104 cells/ml YPD plates containing 0.1 m CsCl, incu-         assigned complementation group.
bated 2 days 24â¬š. concentration CsCl completely         Cloning suppressor locus: pma1-s2 glc7-109 mutant
inhibits growth glc7-109 mutant. 105 Csâ«¹-         strain (TW31) transformed yeast genomic library
tolerant revertants characterized  TW30 (pma1-       CEN URA3 vector YCp50, transformants s1 glc7-109), TW31 (pma1-s2 glc7-109), TW33 (pma1-s3            screened growth 37â¬š failure grow synthetic
glc7-109) isolated culture, TW38 (pma1-s4       media containing 0.1 m CsCl. transformant com-
glc7-109) isolated second culture, TW43            plemented traits obtained approximately
(pma1-s5glc7-109) TW45 (pma1-s6 glc7-109) isolated         66,000 transformants. plasmid (p1407-1) recovered from culture. assay dominance, revertant      transformant verified responsible com- mated glc7-109 strain resulting diploids      plementation retransformation TW31. p1407-1 assayed resistance CsCl glycogen accumulation.           able complement cold sensitivity TW60 (pma1-s1 glc7- determine reversion events extragenic,          109), TW38 (pma1-s4 glc7-109), TW78 (pma1-s6 glc7-109).
revertant mated GLC7 strain, resultant diploids        sequence p1407-1 determined junctions sporulated, tetrad analysis performed assay         vector genomic insert using T7 Sequenase recovery glc7-109 phenotype. Linkage comple-         Version 2.0 (Amersham, Arlington Heights,  primers
mentation suppressors determined             annealed YCp50 vector flanking insert.  1426                                         T. Williams-Hart, X. Wu K. Tatchell

                                                                TABLE 2
                                                                Plasmids

                       Vector                Description                                   Source
         p1407-1           YCp50            CEN4 URA3 PMA1                 YCp50-based genomic library D. S. Conklin
         pAMS366                            2â?® URA3 4XCDRE                 Stathopoulos Cyert (1997)
         pNC160                             CEN3 TRP1                      Rhodes et al. (1990)
         pRS306                             URA3                           Sikorski Hieter (1989)
         pRS316                             CEN6 URA3                      Sikorski Hieter (1989)
         pSB64             pNC160           CEN3 TRP1 glc7-109             Baker et al. (1997)
         pTW2              pRS306           URA3 glc7-109                  study
         pWu361            pNC160           CEN3 TRP1 K259A                study
         pWu363            pNC160           CEN3 TRP1 R260A                study
         pWu365            pNC160           CEN3 TRP1 R260P                study
         pXZ03             YCp50            CEN4 URA3 HA-PMA1              James Haber
         YCp50                              CEN4 URA3                      Rose et al. (1987)
         YEp352                             2â?® URA3                        Hill et al. (1986)



PMA1 gene p1407-1 solely responsible complemen-            dase-conjugated secondary antibody (Amersham). Pma1p lev-
tation revertant phenotype, shown ability         els quantitatively measured using NIH Image phos-
plasmid pXZ03  gift James Haber), contains               phoglycerate kinase loading control compare Pma1p PMA1 gene, complement conditional pheno-              5, 10, 15 â?®g total protein extracts wild-type types restore CsCl sensitivity TW61 (pma1-s1 glc7-109),        glc7-109 cells. Protein concentrations determined 
TW64 (pma1-s2 glc7-109), TW71 (pma1-s4 glc7-109).                 scribed (Bradford 1976) Bio-Rad protein assay 
   Genetic analysis pma1 calcineurin strains:          agent (Bio-Rad Laboratories, Hercules, CA) using bovine se- suppressor strains TW61 (pma1-s1 glc7-109), TW64 (pma1-           rum albumin standard. Membrane fractions separated
s2 glc7-109), TW68 (pma1-s3 glc7-109), TW71 (pma1-s4 glc7-            10  SDS-polyacrylamide gels immunoblotted 
109), TW75 (pma1-s5 glc7-109), TW79 (pma1-s6 glc7-109)            scribed (Ausubel et al. 1989). Total membrane fractions were mated strain TW82 (cnb1::LEU2) TW83 (cnb1::                isolated VO4-sensitive ATPase activity assayed pH 5.7
LEU2). resultant diploid strains sporulated          5 mm ATP described (Serrano 1983b). determine
haploid segregants assayed conditional growth defects        relative membrane potential strains, performed flow growth leuâ«º, salt, drug agar media described               cytometry analysis using FACS Calibur (Becton Dickinson)  mutants containing suppressor (pma1)              described (Madrid et al. 1998).
calcineurin (cnb1::LEU2) characterized.
   l-Leucine uptake assays: l-Leucine uptake assays 
formed previously described (Kotliar et al. 1994; Norbeck Blomberg 1998) modifications. Briefly,                                        RESULTS
l-leucine uptake assays performed wild-type glc7-109 haploid strains grown OD600 âµ‘0.5 (5 â«» 106              glc7-109 mutants recessive, salt sensitive cells/ml) 30â¬š synthetic media supplemented 0.01            dominant, hyperglycogen phenotype: single GLC7
leucine, histidine, uracil. solution l-14C-radiolabeled      mutant (glc7-109) group 20 alanine-scanning
leucine (11.2 GBq/mmol; CEB67, Amersham) 304 mCi/                  mutants uniquely sensitive high concentrations
mmol added cell culture final concentration           NaCl (Baker et al. 1997). accumulated higher 0.05 mm. 1, 2, 3, 4, 5 min, 750-â?®l sample cells
containing l-14C-leucine withdrawn mixed 750 â?®l          normal levels glycogen, observed previously
ice-cold, nonlabeled 0.1 m l-leucine solution stop uptake.         alleles (Baker et al. 1997; Ramaswamy cells immediately filtered washed ice-cold          et al. 1998). crosses strains containing chro-
0.1 m l-leucine solution described. l-14C-radiolabeled         mosomal glc7-109, sensitivity variety monovalent
leucine measurements represent average triplicate ex-
                                                                      divalent ions aminoglycoside antibiotics
periments (Norbeck Blomberg 1998).
   Biochemical methods: assay calcineurin-dependent             segregated hyperglycogen phenotype, indicat-
sponsive element (CDRE)-dependent gene expression, strains            ing single mutation responsible transformed pAMS366 (Stathopoulos-Geron-                    traits. crosses noted salt drug
tides et al. 1999) exponentially growing transformants            sensitivities recessive GLC7 glycogen
(1â€“5 â«» 107 cells/ml) assayed â?¤-galactosidase activity described (Miller 1972; Kaiser et al. 1994). Yeast protein
                                                                      hyperaccumulation trait clearly dominant. shown
extracts prepared described (Stuart et al. 1994)         Figure 1A, diploid strain heterozygous glc7-109
cells density 1 â«» 108 cells/ml precipitated          resistant CsCl paromomycin sulfate 10  trichloroacetic acid described (Dufour Goffeau             wild-type GLC7 strain accumulates glycogen levels
1978). Pma1p levels determined total protein ex-            intermediate glc7-109 homozygous strain
tracts described (Withee et al. 1998) using affinity-purified
rabbit polyclonal antibody generously provided Carolyn             wild type, indicating hyperglycogen
Slayman (Nakamoto et al. 1991). signal visualized             phenotype glc7-109 semidominant. enhanced chemiluminesence horseradish peroxi-                 test possibility dominant glycogen
                                                 Glc7-Dependent Ion Transport                                             1427




   Figure 1. salt sensitivity glycogen hyperaccumula-      Figure 2. nonhydrogen atom model crystal
tion traits glc7-109 mutant separable.   Strains   structure rabbit PP1c (Goldberg et al. 1995) showing incubated YPD medium 24â¬š 2 days         locations amino acid residues altered glc7-109
replica plated agar containing YPD, YPD supplemented       mutant. Amino acid residues make contact GM[63-75] 1 mg/ml paromomycin sulfate (Paro), 0.1 m CsCl,         (Egloff et al. 1997) shown red. R261, amino acid synthetic complete medium stained iodine (I2)       residue altered Glc7-109, shown yellow. colored
described materials methods. glycogen [Gly]          residues PP1c identical Glc7 D242, accumulation strains quantitated described     E241 Glc7. Glc7 lacks amino acid residue NH2
materials methods. strains used wild-type hap-      terminus present PP1c, related amino acids
loid diploid, KT1937 KT1943, respectively; GLC7/        Glc7 PP1c offset residue  e., R261 PP1c
glc7-109, KT1944; glc7-109/glc7-109, KT1945; K259A; glc7-   R260 Glc7). Modeling performed using RasMac v2.6
109, KT1935. (B) Strains incubated YPD medium           software (Roger Sayle, Glaxo Wellcome Medicines Research 24â¬š 2 days replica plated YPD, YPD         Centre).
supplemented 1 mg/ml paromomycin sulfate, 0.1 m
CsCl, 0.9 m NaCl, YPD stained iodine described materials methods. strains used GLC7,            glycogen accumulation (FrancÂ¸ois et al. 1992; Stu-
KT1937; glc7-109 (K259A R260A), WU322; glc7-K259A,
                                                                art et al. 1994) mutations GLC7 GAC1 WU341; glc7-R260A, WU318; glc7-R260P, WU320.
                                                                prevent association cause reduction glycogen
                                                                levels (Stuart et al. 1994; Wu et al. 2001). Gac1 recessive salt-sensitive phenotype glc7-109          likely makes multiple contacts Glc7, judged independently caused missense mutations           locations amino acid substitutions Glc7 glc7-109 (K259A R260A), constructed mutants              exhibit reduced interactions Gac1 (Baker et al. contained single missense mutations. shown          1997; Ramaswamy et al. 1998; Wu et al. 2001). Figure 1B, glc7-R260A confers phenotype similar         contacts hydrophobic channel thought glc7-109 glc7-K259A confers phenotype           interact conserved VXF-motif similar wild type. missense         PP1- Glc7-targeting subunits (Egloff et al. 1997).
mutant proline substituted Arg260 retains          Arg260, residue altered Glc7-109 responsi-
salt paromomycin sulfate sensitivities R260A,        ble hyperglycogen phenotype, near F256, lost hyperglycogen phenotype. fact, glycogen         residue hydrophobic channel makes contact
levels reduced wild type           phenylalanine residue VXF-motif (Egloff
glc7-R260P mutant (Figure 1B). fact glc7-          et al. 1997). Glc7 F256A mutant defects binding
R260P strain retains salt-sensitive trait glc7-     multiple targeting subunits (Wu Tatchell
109 supports hypothesis salt-sensitive         2001), supporting hypothesis residue glycogen traits physiologically unrelated.                  role binding VXF-containing proteins. loca-
   glc7-109 partially bypasses requirement          tions R260 hydrophobic channel high-
Glc7-regulatory subunits glycogen accumulation:             lighted crystal structure PP1 (Figure 2). Glc7 holoenzyme dephosphorylates acti-             basis structure, propose R260 vates glycogen synthase thought contain Gac1,           partially occlude binding Gac1; substitution targeting subunit binds directly Glc7          residue alanine increase affinity glycogen synthase (Wu et al. 2001). Gac1 rate limiting       Gac1, resulting increase concentration  1428                                        T. Williams-Hart, X. Wu K. Tatchell

                                                                  did lower serial dilution, presumably reflecting
                                                                  later stage growth phase. results indicate
                                                                  glc7-109 partially bypasses need Gac1, Pig1,
                                                                  Gip2 glycogen accumulation,                                                                   important implications role Glc7 glycogen
                                                                  metabolism  discussion).
                                                                     Glc7 calcineurin act different pathways
                                                                  affect ion homeostasis: Yeast strains lacking ser/
                                                                  thr protein phosphatase calcineurin/PP2B sensitive
                                                                  high concentrations Naâ«¹, Liâ«¹, Mn2â«¹ (Naka-
                                                                  mura et al. 1993; Breuder et al. 1994; Mendoza et al.
                                                                  1994; Farcasanu et al. 1995), failure                                                                   induce expression number membrane ATPases.
                                                                  sensitivity calcineurin mutants Mn2â«¹                                                                   partly caused reduced transcription PMR1 (Cun-
                                                                  ningham Fink 1996), encoding Golgi P-type
                                                                  ATPase (Antebi Fink 1992); sensitivity Naâ«¹                                                                   Liâ«¹ caused reduced transcription PMR2/ENA1
                                                                  (Mendoza et al. 1994), gene encoding major
                                                                  plasma membrane Naâ«¹ATPase (Rudolph et al. 1989).
                                                                  Calcineurin mutants defective induction                                                                   Pmc1, Ca2â«¹ATPase, causes resistant
   Figure 3.â€”glc7-109 glycogen-targeting subunits. Serial     media containing 200 mm CaCl2 (Cunningham dilutions strains designated genotypes incu-
bated 24 hr 30â¬š YPD, YPD containing 0.1 m CsCl,
                                                                  Fink 1994). transcriptional defects YPD stained iodine. patches lowest     failure calcineurin mutants activate Crz1/Tcn1
serial dilution imaged YPD YPD â«¹ CsCl        transcription factor (Matheos et al. 1997; Statho- lowest second lowest dilutions imaged        poulos Cyert 1997).
iodine-treated samples. strains ascosporal clones       apparent similarity calcineurin cross KT1939 (MATa gac1::LEU2 pig1::URA3) TW321 (MATâ?£ gip2::KanMX glc7-109).
                                                                  glc7-109 phenotypes prompted directly compare
                                                                  mutants. used cnb1::LEU2 null mutant                                                                   comparison. CNB1 encodes conserved regulatory Gac1-Glc7 holoenzyme increased glycogen lev-              subunit calcineurin (Kuno et al. 1991; Cyert els. Consistent hypothesis, detected           Thorner 1992) necessary phosphatase activ-
creased interaction Glc7-109 Gac1 using               ity. cnb1::LEU2 glc7-109 mutants qualita- hybrid assay (D. L. Frederick K. Tatchell,            tive quantitative differences ion sensitivity. unpublished data). occlusion model respon-          glc7-109 mutant generally sensitive mono-
sible hyperglycogen phenotype glc7-109             divalent ions. shown Figure 4, glc7-109
mutant, gac1 null mutation epistatic           mutant fails grow YPD medium containing 25 mm glc7-109. Contrary expectations, glc7-109 gac1::LEU2        CsCl, cnb1::LEU2 strain exhibits defect
mutants accumulate high levels glycogen (Figure 3).            higher concentrations tested (50 100 mm).  Gac1 binding responsible glc7-109            glc7-109 cnb1::LEU2 mutants equally sensitive phenotype.                                                        5 mm MnCl2, glc7-109 mutant sensitive
   yeast genome contains additional genes               Liâ«¹ Naâ«¹ (data shown). Furthermore, products similar Gac1. PIG1, PIG2,               glc7-109 strain does exhibit calcium resistance
GIP2 identified hybrid screen Gsy2-             observed calcineurin mutants (Figure 4). Differ-
interaction proteins (Cheng et al. 1997; Wu et al. 2001)          ences noted temperature dependence Gip2 identified independently Glc7p-          Liâ«¹ sensitivity glc7-109 cnb1::LEU2 strains. interacting protein (Tu et al. 1996). null muta-         glc7-109 mutant exhibits greater sensitivity LiCl 24â¬š
tions genes reported little effect          30â¬š, temperature differential glycogen levels, tested products             noted cnb1::LEU2 strain. additional differ- necessary hyperglyco-           ence sensitivity aminoglycoside antibiotics.
gen phenotype glc7-109 mutant. Glycogen levels             cnb1::LEU2 mutant does exhibit growth defects elevated glc7-109 strains containing deletions            media containing 50 â?®g/ml hygromycin B (Figure GAC1, PIG1, GIP2 stationary phase,              4) 1 mg/ml paromomycin sulfate (data shown)
glycogen levels dropped wild type.           contrast hypersensitivity glc7-109 mutants.
shown Figure 3, higher serial dilution gac1         indication Glc7 calcineurin act separate
pig1 gip2 glc7-109 strain stained iodine vapor          pathways finding glc7-109 cnb1::LEU2 dou-
                                                Glc7-Dependent Ion Transport                                              1429




  Figure 4. phenotypes glc7-109 calcineurin-deficient (cnb1::LEU2) mutants. Serial dilutions strains incubated indicated agar media 2â€“4 days 24â¬š. strains used wild type (KT1112), glc7-109 (TW25),
cnb1::LEU2 (TW82), glc7-109 cnb1::LEU2 (TW90).



ble mutant sensitive ions                   glc7-109 strain exhibits increased rates l-leu-
single mutants. Glc7 calcineurin act           cine uptake: glc7-109 mutant hypersensitive pathway affect ion homeostasis, pre-             aminoglycoside antibiotics paromomycin sulfate
dict epistatic relationship mutants.           hygromycin B. mechanisms action Instead, ion defects conferred           antibiotics different, likely mutations additive synergistic; glc7-109           hypersensitivity glc7-109 strains drugs cnb1 mutant sensitive Mn2â«¹, Liâ«¹, Csâ«¹               caused defects uptake export. single mutant (Figure 4). Calcineurin              able distinguish exerts physiological effects regu-        possibilities, note glc7-109 strains grow lation transcription factor Tcn1/Crz1 (Matheos             rapidly wild type synthetic media containing
et al. 1997; Stathopoulos Cyert 1997; Statho-                 low concentrations amino acids (data shown).
poulos-Gerontides et al. 1999). shown Table 3,              confirm difference change cnb1::LEU2 strain fails induce expression           amino acid uptake measured l-leucine uptake CRZ1-dependent Lac gene. levels â?¤-galactosi-             glc7-109 mutants rate l-leucine uptake dase activity glc7-109 strain 35â€“70           glc7-109 mutant approximately twofold higher wild type orders magni-        wild type (Table 3).
tude higher cnb1::LEU2 strain.               defects glc7-109 Kâ´™ remedial: rule data indicate substrates calcineurin            possibility sensitivity glc7-109 mutants Glc7 responsible ion sensitivities         high concentrations ions osmotic ef- likely different.                                       fects, tested growth properties glc7-109 strains



                                                          TABLE 3
                                          Comparison glc7-109 cnb1 mutants

                                          CDRE activationa
                                                                               l-Leucine      Pma1          Pma1
        Genotype          Uninduced     Induced (Ca2â«¹)       Induced (Mn2â«¹)     uptakeb      amountc       activityd
        GLC7 CNB1          88 â«¾ 7.0       1314 â«¾ 185          2212 â«¾ 56       2.10 â«¾ 0.26      100       0.24 â«¾ 0.01
        glc7-109 CNB1      73 â«¾ 9.1        946 â«¾ 245           770 â«¾ 153      5.62 â«¾ 1.2     90 â«¾ 17     0.20 â«¾ 0.02
        GLC7 cnb1           3 â«¾ 0.6          3 â«¾ 0.6             2 â«¾ 0.6          ND           ND            ND
          ND, determined.
                      Wild-type (KT1112), glc7-109 (KT1596), calcineurin-deficient (TW82) strains transformed         pAMS366, contains calcineurin-dependent responsive elements (4XCDREs) LacZ reporter gene
        (Stathopoulos Cyert 1997). CDRE activation quantitated Miller units â?¤-galactosidase activity
        (Miller 1972). â?¤-Galactosidase activity measured described materials methods growth
        selective media media supplemented 200 mm CaCl2 10 mm MnCl2 indicated. Values represent
        average separate experiments.
          b
            Micromoles [14C]leucine gram dry weight minute; data represent average separate
        experiments.
          c
            abundance Pma1 protein cell extracts determined described materials         methods. Values represented median percentage Pma1 relative 100  wild type (KT1112)
        separate determinations.
          d
            Inorganic phosphate (micromoles milligram minute) liberated; values presented represent         average separate experiments.
 1430                                       T. Williams-Hart, X. Wu K. Tatchell

                                                                 cessive, shown CsCl sensitivity diploid strains
                                                                 heterozygous suppressor mutations homozy-
                                                                 gous glc7-109. determine mutations respon-
                                                                 sible suppression extragenic GLC7, tetrad
                                                                 analysis performed diploid strains created                                                                  mating revertants wild-type strain.
                                                                 salt-sensitive phenotype glc7-109 observed                                                                  approximately fourth spore clones                                                                  cross, indicating mutation responsible                                                                  reversion unlinked GLC7. determine                                                                  suppressors complementation group,
                                                                 diploid strains constructed homozygous
                                                                 glc7-109 heterozygous different suppres-
                                                                 sors. diploids resistant 0.1 m CsCl, indicating
                                                                 suppressors complementation
                                                                 group. Furthermore, tetrad analysis meiotic progeny
                                                                 diploid strains revealed spore clones
                                                                 retained Csâ«¹-resistant phenotype parents,
                                                                 indicating suppressor loci tightly linked.
                                                                    suppressors genetically linked,
                                                                 confer diverse phenotypes. revertants
  Figure 5.â€”KCl suppresses salt drug sensitivities    able grow media containing 0.1 m CsCl 0.9 glc7-109 mutant. Serial dilutions wild type (KT1112)      m NaCl, pma1-s1, pma1-s3, pma1-s4 suppress glc7-109 (TW25) strains incubated 2â€“4 days       Liâ«¹ defect glc7-109 (Figure 6). contrast, pma1-
24â¬š media containing YPD, YPD containing 1 m KCl, 0.05 m      s1 pma1-s4 strains actually grow better wild-
CsCl, 0.05 m CsCl â«¹ 0.2 m KCl, 0.1 m LiCl, 0.1 m LiCl â«¹ 0.2 m
KCl, 50 â?®g/ml hygromycin B, 50 â?®g/ml hygromycin B â«¹ 0.2 m        type strain 0.1 m LiCl (Figure 6). revertant strains
KCl, 1 mg/ml paromomycin sulfate, 1 mg/ml paromomy-          containing pma1-s2 exhibit glc7-109
cin sulfate â«¹ 0.2 M KCl.                                         growth defect 10 mm MnCl2 (Figure 6).                                                                  revertants conditional growth defects                                                                  glc7-109 genetic background. pma1-s2 pma1-s5
                                                                 strains grow slowly wild-type strain 37â¬š YPD media containing 1 m KCl 1 m sorbitol.                pma1-s1, pma1-s4, pma1-s6 strains grow growth defects observed media              slowly wild type 15â¬š (Figure 6). KCl sorbitol, KCl partially relieved salt        suppressor mutants characterized wild-
drug sensitivities glc7-109 strains. presence          type GLC7 background. pma1-s6 strains grow poorly 200 mm KCl medium reduces sensitivity              0.1 m CsCl 0.1 m LiCl, pma1-s2 grows poorly
glc7-109 Csâ«¹, Liâ«¹, hygromycin B, paromomycin              LiCl (Figure 7). contrast, pma1-s1, pma1-s3,
sulfate (Figure 5), Mn2â«¹ Naâ«¹ (data                pma1-s4, pma1-s5 strains grow faster wild-
shown). Kâ«¹ remedial phenotype caused glc7-109             type strain LiCl (Figure 7). conditional
led examine effect growth low concentra-         growth defects observed glc7-109 background tions KCl, mutants defective potassium         apparent GLC7â«¹ background. example,
transporters Trk1 Trk2 hypersensitive hygro-          pma1-s1 pma1-s4 strains grow slowly mycin B toxic cations (Mulet et al. 1999). Growth            wild type 15â¬š (Figure 7) pma1-s2 strains grow yeast cells media containing low concentrations            slowly wild type 37â¬š (data shown). KCl (0.2 mm) requires activity high-affinity          glc7-109 suppressors allelic PMA1, encod-
Kâ«¹ transporter encoded TRK1 (Gaber et al. 1988).              ing essential plasma membrane Hâ´™ATPase: sup- trk1 strain (TW272) failed grow            pressor locus cloned complementation synthetic medium containing 0.2 mm KCl glc7-             temperature sensitivity strain TW64 (pma1-s2 glc7-
109 wild-type strains grew equally           109) described materials methods. dium.  ion sensitivities glc7-109           complementing plasmid clone (p1407-1) comple-
mutant unlikely caused defect high-            mented cold-sensitive defects strains TW30 (pma1-
affinity Kâ«¹ transport.                                           s1 glc7-109) TW38 (pma1-s4 glc7-109). trans-
   Suppressors Csâ´™-sensitive phenotype glc7-           formants grew 37â¬š 15â¬š, failed grow
109: characterized spontaneous glc7-109                0.1 m CsCl media. Sequence analysis revealed vertants grew YPD medium containing 0.1 m                genomic insert p1407-1 contained PMA1 CsCl, described materials methods.                 adjacent 378-bp open reading frame, YGL007. plasmid
mutations responsible reversion events           (pXZ03) containing PMA1 lacking YGL007                                                 Glc7-Dependent Ion Transport                                               1431




  Figure 6.â€”pma1 mutations suppress Csâ«¹ sensitivity conferred glc7-109. Serial dilutions pma1 mutants glc7-109
background plated YPD medium, YPD media supplemented designated salts, synthetic complete (SC)
medium. plates incubated 2 4 days. strains used wild type (KT1112), glc7-109 (TW25), pma1-
s1 glc7-109 (TW30), pma1-s2 glc7-109 (TW31), pma1-s3 glc7-109, (TW33), pma1-s4 glc7-109 (TW38), pma1-s5 glc7-109 (TW43), pma1-s6 glc7-109 (TW45).



able suppress temperature sensitivity Csâ«¹             strongly suppress glc7-109 showed greatest
resistance TW64 (pma1-s2 glc7-109), indicating           suppression cnb1::LEU2.
PMA1 responsible complementation.                 pma1 mutants sensitive low pH (McCusker
firm suppressor mutations alleles PMA1,          et al. 1987; Withee et al. 1998). compared growth mapped distance pma1-s4 leu1,                 glc7-109 mutant cold-sensitive pma1 mutant lies âµ‘1 cM centromere proximal PMA1. Tetrad             strain, TW71 (pma1-s4 glc7-109), liquid YPD media analysis cross KT1850 (MATâ?£ ura3-52 his3            pH 3, 5, 8.5. pH 5, growth wild-type,
glc7-109 pma1-s4) KT1849 (MATa ura3-52 his3 leu1)            glc7-109, pma1-s4 glc7-109 strains compara-
revealed distance leu1 pma1-s4 1.1       ble (data shown). expected, suppressor strain
cM (P:NP:T â«½ 43:0:1), identical previously deter-         TW71 (pma1-s4 glc7-109) grows slowly acidic pH mined map distance (P:NP:T â«½ 869:0:22; McCusker              unexpectedly, glc7-109 strain grows slowly alkaline
Haber 1988).  linkage complementa-              pH (Figure 8).
tion data indicate glc7-109 suppressors            ability pma1 mutations suppress salt-
alleles PMA1.                                                 sensitive phenotype glc7-109 led assay Pma1
   PMA1 mutants isolated suppress             levels activity glc7-109 pma1-s4 mutants. Pma1
salt sensitivities calcineurin mutants (Nass et al. 1997;     levels glc7-109 strain âµ‘90  wild
Withee et al. 1998). determine glc7-109 sup-           type, assayed immunoblot analysis. Vanadate-sensi-
pressors suppress defects, crossed strains         tive ATPase activities, measure Pma1 activity, containing suppressors cnb1 strain          comparable wild-type glc7-109 strains (Table
assayed meiotic products salt sensitivity.         3), pma1-s4 mutant 61  wild suppressors fail suppress ion sensitivities        type (data shown). Indirect immunofluorescence cnb1, partially suppress Naâ«¹          revealed obvious differences glc7-109 Liâ«¹ defects cnb1 strain (Table 4).             wild-type strains Pma1 localization (data shown). cold-sensitive mutations (pma1-s1 pma1-s4)           compelling evidence glc7-109 di-




                                                                                Figure 7. phenotype pma1 mutants
                                                                             GLC7 background. Serial dilutions pma1
                                                                             mutants GLC7â«¹ background plated                                                                              YPD medium, YPD media supplemented                                                                              designated salts, synthetic complete (SC) 
                                                                             dium. plates incubated 2â€“4 days.
                                                                             strains used wild type (KT1112),
                                                                             glc7-109 (TW25), pma1-s1 (TW62), pma1-s2 (TW65),
                                                                             pma1-s3 (TW69), pma1-s4 (TW72), pma1-s5 (TW76),
                                                                             pma1-s6 (TW80).
 1432                                      T. Williams-Hart, X. Wu K. Tatchell

                                                          TABLE 4
                                              Phenotype glc7-109 suppressors

                             Phenotype                                                             cnb1::LEU2
                           pma1 mutant                  glc7-109 mutant defects                mutant defects
        Suppressor         GLC7 background                     suppressed pma1a                suppressed pma1
        pma1-s1                    cs                Css, Nas, Lis, Mns, paro.s, hygro.s          Nas, Lis
        pma1-s2                    ts                Css, Mns, paro.s, hygro.s                    Lis
        pma1-s3                    â€”                 Css, Nas, Lis, paro.s, hygro.s                          â€”
        pma1-s4                    cs                Css, Nas, Lis, Mns, OHâ«ºs, paro.s, hygro.s    Nas, Lis
        pma1-s5                    â€”                 Css, Nas, Mns, paro.s, hygro.s                          â€”
                                                     Css, Nas, Mns, paro.s, hygro.s
        pma1-s6                   Lis                                    â€”
          growth pma1 mutants genetic backgrounds tested various media described         materials methods. cs, reduced growth rate 15â¬š; ts, reduced growth rate 37â¬š; Lis, unable grow
        0.1 m LiCl; Css, unable grow 0.1 m CsCl; Nas, unable grow 0.9 m NaCl media; Mns, unable         grow 0.01 m MnCl2 media; paro., unable grow 1 mg/ml paromomycin sulfate media; hygro., unable
        grow 50 â?®g/ml hygromycin B media; OHâ«ºs, reduced growth alkaline pH.
                      pma1-s4 glc7-109 mutant (TW75) glc7-109 suppressor tested suppression glc7-
        109 growth acidic alkaline pH.




rectly influences activity, abundance, distribution                                  DISCUSSION Pma1.                                                              Like glc7 mutations, glc7-109 pleiotropic.
   glc7-109 cells hyperpolarized: potassium-            glc7-109 mutant hyperaccumulates glycogen remedial sensitivity glc7-109 mutants toxic cations,         sensitive wide range cations, high pH, high pH, aminoglycoside antibiotics sup-               aminoglycoside antibiotics. analysis single
pression defects mutations PMA1                 missense mutations make glc7-109 indicated consistent hypothesis plasma mem-                R260A substitution responsible traits
brane potential glc7-109 mutant hyperpolarized.          conferred glc7-109. likely hyperglycogen conventional determination membrane potential                 trait ion drug hypersensitivity traits reflect
using electrophysiological methods possible              influence Glc7 separate physiologi-
yeast, relative membrane potentials assessed            cal processes. glycogen phenotype
using fluorescent dyes. methods suffer               glc7-109 dominant, traits complications caused contribution               recessive, glc7-R260P confers ion-
mitochondria uptake process, Madrid et al.                  related defects hyperglycogen phenotype.
(1998) shown cellular fluorescence                Yeast PP1 associated glycogen metabolism
cyanine dye DiOC6(3) determined condi-                years; acronym derived glycogen
tions mitochondria interfere.              deficiency glc7-1 (Cannon et al. 1994).  glc7-
followed procedure closely growing strains             109 allele glc7 knowledge low density glucose-containing medium assaying              linked ion homeostasis.
DiOC6(3) fluorescence levels flow cytometry.                    glc7-109 glycogen: yeast, mammals, PP1
shown Table 5, DiOC6(3) fluorescence glc7-               thought dephosphorylate activate glycogen
109 strain (KT1596) âµ‘150â€“200  wild-                synthase. PP1 activity glycogen synthase type strain. contrast, DiOC6(3) fluorescence               thought regulated targeting subunits tether
pma1-s4 strain, TW72, 30â€“40  wild type            PP1c glycogen synthase. Abundant evidence indicates pma1-s4 glc7-109 strain (TW71)            Gac1 plays role yeast. gac1 null mutants
50â€“60  wild type. control, assayed DiOC6(3)             accumulate low levels glycogen glycogen synthase
fluorescence wild-type strain grown synthetic              strains remains phosphorylated, inactive
media containing low concentration Kâ«¹,               form (FrancÂ¸ois et al. 1992). product glc7-1, known hyperpolarize plasma membrane (Madrid                 original glycogen-deficient allele GLC7, fails inter-
et al. 1998). DiOC6(3) fluorescence wild-type cells             act Gac1 (Stuart et al. 1994). Gac1 contains sepa- conditions 450â€“650  wild-type               rate domains required binding Glc7 glycogen
cells grown YPD medium (data shown).                 synthase, required functional activ-
sults assays suggest defects          ity (Wu et al. 2001). Mutations glycogen synthase
glc7-109 strains caused hyperpolarized             kinase, Pho85/Pcl10, suppress glycogen deficiency
plasma membrane activation nonspecific              glc7-1 gac1 strains (Huang et al. 1996, 1998; Tim-
ion conductance.                                                   blin et al. 1996). Furthermore, mutations major
                                               Glc7-Dependent Ion Transport                                           1433

                                                                                        TABLE 5
                                                                       Relative membrane potential measurements

                                                                             Relevant                      Fluorescence
                                                              Strain         genotype       400 mm KCl     DiOC6(3                                                               KT1112     GLC7 PMA1                â«º            100
                                                                                                  â«¹          55 â«¾ 5
                                                              KT1596     glc7-109 PMA1            â«º         177 â«¾ 18
                                                                                                  â«¹         100 â«¾ 10
                                                              TW72       GLC7 pma1-s4             â«º          36 â«¾ 14
                                                              TW71       glc7-109 pma1-s4         â«º          56 â«¾ 14
                                                                                                                                  Fluorescence intensity DiOC6(3) glc7-109 (KT1596),
                                                              pma1-s4 (TW72), pma1-s4 glc7-109 (TW71) strains ex-
                                                              pressed percentage wild-type levels  materials
                                                              methods). Values represent average separate
                                                              experiments performed separate days.



                                                              possibility degradative pathway altered
                                                              glc7-109 strains. worth noting Pho85,                                                               kinase phosphorylates glycogen synthase, regu-
                                                              lates activity glycogen phosphorylase                                                               cyclins Pcl6 Pcl7 (Wang et al. 2001). Furthermore,
                                                              large-scale analysis protein complexes                                                               Gip2 Glc7 associate glycogen phosphory-
                                                              lase (Ho et al. 2002), suggesting Glc7, possibly
                                                              targeting subunits, regu-
                                                              late glycogen phosphorylase glycogen syn-
                                                              thase. possibility Glc7-109 mutant
  Figure 8. growth glc7-109 mutant pma1-   protein longer requires glycogen-targeting subunits
s4 glc7-109 mutant YPD medium adjusted pH 3 8.5.
Log-phase cultures strain incubated liquid
                                                              increase Vmax glycogen synthase, assuming
YPD media pH 3 8.5 described materials       role glycogen-targeting subunits yeast.
methods. growth strain monitored optical   direct biochemical evidence effect density 660 nm. strains used wild type   PP1-targeting subunit smooth muscle (Tanaka et
(KT1112), glc7-109 (TW25), pma1-s4 glc7-109 (TW71).       al. 1998) genetic evidence role                                                               yeast. Small fragments Gac1 contain isoform glycogen synthase, Gsy2, phos-      Glc7-binding domain partially complement glyco-
phorylated suppress glycogen deficiencies         gen deficiency gac1 null mutant expressed glc7-1 gac1 strains (Hardy Roach 1993; Ander-         high levels (Wu et al. 2001). Clearly, genetic
son Tatchell 2001).  data suggest          biochemical studies necessary sort Gac1 acts molecular scaffold tether Glc7         complex roles Glc7 glycogen metabolism. Gsy2. surprised discover           Glc7 ion homeostasis: pleiotropic salt- hyperglycogen trait glc7-109 epistatic gac1    drug-sensitive phenotype conferred glc7-109 null mutation. Glycogen levels remain high strains         accounted broad mechanisms. disrupted GAC1 GAC1-related genes, PIG1           possible explanation glc7-109 mutant GIP2.                                                     hyperpolarized plasma membrane potential. Neuro-
   explanation results additional       spora crassa, membrane voltage measurements
glycogen-targeting subunits substitute loss       performed (Slayman 1965a,b), plasma mem- Gac1, Pig1, Gip2. Pig2 candidate       brane Hâ«¹ATPase largely responsible maintaining
redundant subunit. similar sequence          membrane voltage (Slayman et al. 1973; Gradmann
Gip2 loss function mutations PIG2          et al. 1978). S. cerevisiae, mutants gene encoding alter glycogen levels, possi-    plasma membrane Hâ«¹ATPase, PMA1, 
ble Glc7-109 recruit Pig2 absence        ferred reduced membrane potential (Perlin targeting subunits. possibility     et al. 1988; Seto-Young Perlin 1991), defects
high levels glycogen glc7-109 strains partially     general opposite glc7-109 mutants, changes activity enzymes          exhibiting increased resistance drugs toxic ca-
glycogen synthase. assayed activity levels        tions (McCusker et al. 1987). contrast, yeast cells glycogen synthase strains rule        defects plasma membrane Kâ«¹ transporters
 1434                                      T. Williams-Hart, X. Wu K. Tatchell

encoded TRK1 TRK2 inferred             Trk2. Surprisingly, current independent Kâ«¹ increased membrane potential (Madrid et al. 1998)            independent Trk1. possible scenario phenotype similar, identical,        arising studies Kâ«¹ transporters glc7-109 mutant (Vidal et al. 1990; Madrid       auxiliary function unrelated Kâ«¹ trans-
et al. 1998; Mulet et al. 1999). Direct measurements         port, strongly regulates membrane potential. membrane potential S. cerevisiae possible        related protein kinases, Hal4 Hal5, modulate
technical reasons indirect determinations using fluo-       Trk1 Trk2 activity (Mulet et al. 1999). Yeast cells
rescent dyes subject artifacts (Ballarin-Denti et al.    lacking Hal4 Hal5 phenotype similar 1994).  analysis DiOC6(3) fluores-          trk1 trk2 strains, including hypersensitivity toxic
cence consistent hyperpolarization plasma        cations hygromycin B deficiency Kâ«¹ uptake.
membrane glc7-109 cells. isolation mutations          contrast, increased expression Hal4 Hal5 results PMA1 suppressors CsCl sensitivity glc7-         resistance Liâ«¹ Naâ«¹ (Mulet et al. 1999). 109 mutants supports hypothesis.                   results suggest Hal4 Hal5 positive regulators
   Glc7 act influence membrane poten-              Trk1 Trk2.  Glc7 regulates Kâ«¹ trans-
tial? obvious possibilities Pma1           port, probably does simply opposing potassium transporters, Trk1 Trk2. Pma1             kinase activity Hal4 Hal5 glc7-109 confers essential maintenance plasma membrane             similar phenotype hal4 hal5 null mutant.
potential activity regulated response           alternative explanation hyperpolarization range external factors. Pma1 phosphorylated            pleiotropic drug- ion-hypersensitive phenotype
multiple sites classes protein kinases      glc7-109 mutant glc7-109 results regulate activity (Kolarov et al. 1988; Berto-          activation nonspecific uptake mechanism 
rello et al. 1991; Serrano et al. 1991). protein            ductance. scenario, reduction Pma1 activity
kinase Ptk2 positive regulator Pma1 appears         application exogenous Kâ«¹ suppress act activating phosphorylation site           drug ion toxicity glc7-109 mutation Ser-899 (Goossens et al. 2000). contrast, Yck1           indirect effects. regard, note Bihler et Yck2 kinases act negative regulators Pma1         al. (1998) identified nonspecific cation channel
activity (Estrada et al. 1996).  Pma1 likely          S. cerevisiae patch-clamping yeast spheroplasts. candidate regulated Glc7.          conductance, termed nonselective cation channel 1 direct involvement Glc7 Pma1 regulation.          (NSC1), carries large inward current low ca-
Pma1 levels Pma1-dependent Hâ«¹ATPase activities              tion specificity. NSC1 independent Trk1, Trk2, similar glc7-109 GLC7 strains,         potassium channel Duk1/Tok1, gene exclude possibility glc7-109 exerts subtle effect    genes encoding channel identified. Pma1 activity Glc7 regulates Pma1 response        possible NSC1 remains open glc7-109 mu- specific environmental stresses.                             tants, causing increased toxicity cations.    potassium transporters Trk1 Trk2            course, exclude possibility Glc7 candidates Glc7 regulation. Like glc7-109, trk1         multiple targets influence ion homeostasis. trk1 trk2 double mutants exhibit high levels DiOC6(3)        GLC7 mutants pleiotropic unreasonable
fluorescence (Madrid et al. 1998) share traits           propose multiple substrates affected glc7-
common glc7-109, including sensitivity toxic ca-        109 strains. genetic analysis allow tions hygromycin B (Mulet et al. 1999).             identify targets.
unlike mutants lacking potassium transporters,            thank Carolyn Slayman Ken Allen providing antibody
glc7-109 mutant exhibits obvious growth defect            Pma1 helpful advice concerning Pma1 activity assays. media containing low concentrations potassium. glc7-         acknowledge Martha Cyert, James Haber, Peter Roach kindly
                                                                providing strains plasmids. thank Andrew Bloecher, Lucy
109 confers sensitivity alkaline pH opposed
                                                                Robinson, Heather Panek, Clifford Slayman, Guglielmo M. Ven- acidic pH sensitivity trk1 mutants. Surprisingly,     turi helpful discussions. gratefully acknowledge Clifford Slay-
Kâ«¹ transport regulation membrane potential           man Lucy Robinson critically reading manuscript. independent properties Trk1 Trk2. Madrid              work funded National Institutes Health research grant GM-
et al. (1998) trk1 trk2 mutants expressing      47789. Kâ«¹ transporter (HAK1) Schwanniomyces occiden-
talis unrelated structure Trk1 Trk2 exhibit
                                                                                      LITERATURE CITED
normal levels Kâ«¹ transport retain hyperpolar-
ization trk1 trk2 mutant. contrast, expression        Allen, P. B., C. C. Ouimet P. Greengard, 1997 Spinophilin,
                                                                    novel protein phosphatase 1 binding protein localized den- plant Kâ«¹ transporter related Trk1 suppresses                dritic spines. Proc. Natl. Acad. Sci. USA 94: 9956â€“9961. Kâ«¹ transport membrane potential defects            Anderson, C., K. Tatchell, 2001 Hyperactive glycogen syn- trk1 trk2 mutants. Using patch clamping yeast                 thase mutants Saccharomyces cerevisiae suppress glc7-1 protein
                                                                    phosphatase mutant. J. Bacteriol. 183: 821â€“829.
spheroplasts, Bihler et al. (1999) observed          Andre, B., 1995 overview membrane transport proteins ward, Hâ«¹-dependent current dependent                   Saccharomyces cerevisiae. Yeast 11: 1575â€“1611.
                                                           Glc7-Dependent Ion Transport                                                          1435
Andrews, P. D., M. J. Stark, 2000 Type 1 protein phosphatase                 yeast plasma membrane ATPase changes growth
    required maintenance cell wall integrity, morphogenesis            conditions gene dosage. FEBS Lett. 224: 193â€“197.
    cell cycle progression Saccharomyces cerevisiae. J. Cell Sci.     Estrada, E., P. Agostinis, J. R. Vandenheede, J. Goris, W. Merlevede
    113: 507â€“520.                                                                et al., 1996 Phosphorylation yeast plasma membrane Hâ«¹-
Antebi, , G. R. Fink, 1992 yeast Ca(2â«¹)-ATPase homo-                   ATPase casein kinase  J. Biol. Chem. 271: 32064â€“32072.
    logue, PMR1, required normal Golgi function localizes         Farcasanu,  C., D. Hirata, E. Tsuchiya, F. Nishiyama T.
    novel Golgi-like distribution. Mol. Biol. Cell 3: 633â€“654.              Miyakawa, 1995 Protein phosphatase 2B Saccharomyces cere-
Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman             visiae required tolerance manganese, blocking     et al., 1989 Current Protocols Molecular Biology. John Wiley &            entry ions cells. Eur. J. Biochem. 232: 712â€“717.
    Sons, New York.                                                          Feng, , S. E. Wilson, -Y. Peng, K. K. Schlender, E. M. Reimann
Bailis, J. M., G. S. Roeder, 2000 Pachytene exit controlled               et al., 1991 yeast GLC7 gene required glycogen accumu-
    reversal Mek1-dependent phosphorylation. Cell 101: 211â€“221.               lation encodes type 1 protein phosphatase. J. Biol. Chem. 266:
Baker, S. H., D. L. Frederick,  Bloecher K. Tatchell, 1997                 23796â€“23801.
    Alanine scanning mutagenesis protein phosphatase type 1            FrancÂ¸ois, J. M., S. Thompson-Jaeger, J. Skroch, U. Zellenka, W.
    yeast Saccharomyces cerevisiae. Genetics 145: 615â€“626.                   Spevak et al., 1992 GAC1 encode regulatory subunit Ballarin-Denti, , C. L. Slayman H. Kuroda, 1994 Small                      protein phosphatase type 1 Saccharomyces cerevisiae. EMBO J.
    lipid-soluble cations membrane voltage probes Neuro-             11: 87â€“96.
    spora Saccharomyces. Biochim. Biophys. Acta 1190: 43â€“56.              Gaber, R. F., C.  Styles G. R. Fink, 1988 TRK1 encodes Bertorello,  M.,  Aperia, S.  Walaas,  C. Nairn P.                   plasma membrane protein required high-affinity potassium
    Greengard, 1991 Phosphorylation catalytic subunit                  transport Saccharomyces cerevisiae. Mol. Cell. Biol. 8: 2848â€“2859.
    Naâ«¹,K(â«¹)-ATPase inhibits activity enzyme. Proc. Natl.         Garcia-Arranz, M.,  M. Maldonado, M. J. Mazon F. Portillo,
    Acad. Sci. USA 88: 11359â€“11362.                                              1994 Transcriptional control yeast plasma membrane H(â«¹)-
Bihler, H., C. L. Slayman  Bertl, 1998 NSC1: novel high-                 ATPase glucose. Cloning characterization new gene
    current inward rectifier cations plasma membrane               involved regulation. J. Biol. Chem. 269: 18076â€“18082.
    Saccharomyces cerevisiae. FEBS Lett. 432: 59â€“64.                         Gietz, D.,  St. Jean, R.  Woods R. H. Schiestl, 1992 Im-
Bihler, H., R. F. Gaber, C. L. Slayman  Bertl, 1999                    proved method high efficiency transformation intact yeast
    presumed potassium carrier Trk2p Saccharomyces cerevisiae              cells. Nucleic Acids Res. 20: 1425.
    termines Hâ«¹-dependent, Kâ«¹-independent current. FEBS                   Goldberg, J., H. B. Huang, Y. G. Kwon, P. Greengard,  C. Nairn
    Lett. 447: 115â€“120.                                                          et al., 1995 dimensional structure catalytic subunit
Bloecher, , K. Tatchell, 1999 Defects Saccharomyces cere-               protein serine/threonine phosphatase-1. Nature 376: 745â€“753.
    visiae protein phosphatase type activate spindle/kinetochore       Gong, X.,  Chang, 2001 mutant plasma membrane ATPase,
    checkpoint. Genes Dev. 13: 517â€“522.                                          Pma1â€“10, defective stability yeast cell surface. Proc.
Bradford, M. M., 1976 Rapid sensitive method quantitation                Natl. Acad. Sci. USA 98: 9104â€“9109.
    microgram quantities protein utilizing principle pro-       Goossens, , N. La Fuente, J. Forment, R. Serrano F.
    tein-dye binding. Anal. Biochem. 72: 248â€“254.                                Portillo, 2000 Regulation yeast H(â«¹)-ATPase protein
Breuder, T., C. S. Hemenway, N. R. Movva, M. E. Cardenas                     kinases belonging family dedicated activation plasma
    J. Heitman, 1994 Calcineurin essential cyclosporin               membrane transporters. Mol. Cell. Biol. 20: 7654â€“7661.
    FK506-sensitive yeast strains. Proc. Natl. Acad. Sci. USA 91: 5372â€“      Gradmann, D., U. P. Hansen, W. S. Long, C. L. Slayman J.
    5376.                                                                        Warncke, 1978 Current-voltage relationships plasma
Browning, M. D., R. Huganir P. Greengard, 1985 Protein                       membrane principal electrogenic pump Neurospora
    phosphorylation neuronal function. J. Neurochem. 45:                     crassa:  Steady-state conditions. J. Membr. Biol. 39: 333â€“367.
                                                                             Greengard, P.,  C. Nairn, J.  Girault, C. C. Ouimet, G. L.
    11â€“23.
                                                                                 Snyder et al., 1998 DARPP-32/protein phosphatase-1 cas-
Cannon, J. F., J. R. Pringle,  Fiechter M. Khalil, 1994 Char-
                                                                                 cade: model signal integration. Brain Res. Brain Res. Rev.
    acterization glycogen-deficient glc mutants Saccharomyces
                                                                                 26: 274â€“284.
    cerevisiae. Genetics 136: 485â€“503.
                                                                             Guthrie, C., G. R. Fink, 1991 Guide Yeast Genetics Molecular
Capieaux, E., M. L. Vignais,  Sentenac  Goffeau, 1989
                                                                                 Biology. (Methods Enzymology, Vol. 194). Academic Press, San
    yeast Hâ«¹-ATPase gene controlled promoter binding
                                                                                 Diego.
    factor TUF. J. Biol. Chem. 264: 7437â€“7446.
                                                                             Hardy, T. , P. J. Roach, 1993 Control yeast glycogen
Chang, , C. W. Slayman, 1991 Maturation yeast plasma
                                                                                 synthase-2 COOH-terminal phosphorylation. J. Biol. Chem.
    membrane [Hâ«¹]ATPase involves phosphorylation intra-
                                                                                 268: 23799â€“23805.
    cellular transport. J. Cell Biol. 115: 289â€“295.                          Hasper, , P. Soteropoulos D. S. Perlin, 1999 Modification
Cheng, C., D. Huang P. J. Roach, 1997 Yeast PIG genes: PIG1                  N-terminal polyserine cluster alters stability plasma
    encodes putative type 1 phosphatase subunit interacts            membrane H(â«¹)-ATPase Saccharomyces cerevisiae. Biochim.
    yeast glycogen synthase Gsy2p. Yeast 13: 1â€“8.                            Biophys. Acta 1420: 214â€“222.
Chester, V. E., 1968 Heritable glycogen-storage deficiency yeast           B., M. Gross B. Roizman, 1998 gamma134.5 protein
    induction ultra-violet light. J. Gen. Microbiol. 51: 49â€“56.       herpes simplex virus 1 structural functional attri-
Cunningham, K. W., G. R. Fink, 1994 Calcineurin-dependent                    butes protein phosphatase 1 regulatory subunit present
    growth control Saccharomyces cerevisiae mutants lacking PMC1,             high molecular weight complex enzyme infected
    homolog plasma membrane Ca2â«¹ ATPases. J. Cell Biol. 124:                cells. J. Biol. Chem. 273: 20737â€“20743.
    351â€“363.                                                                 Hill, J. E.,  M. Myers, T. J. Koerner  Tzagoloff,
Cunningham, K. W., G. R. Fink, 1996 Calcineurin inhibits                     1986 Yeast/E. coli shuttle vectors multiple unique restric-
    VCX1-dependent Hâ«¹/Ca2â«¹ exchange induces Ca2â«¹                             tion sites. Yeast 2: 163â€“167.
    ATPases Saccharomyces cerevisiae. Mol. Cell. Biol. 16: 2226â€“2237.     Hisamoto, N., D. L. Frederick, K. Sugimoto, K. Tatchell K.
Cyert, M. S., J. Thorner, 1992 Regulatory subunit (CNB1 gene                 Matsumoto, 1995 EGP1 gene positive regulator
    product) yeast Ca2â«¹/calmodulin-dependent phosphoprotein                   protein phosphatase type 1 growth control Saccharo-
    phosphatases required adaptation pheromone. Mol. Cell.             myces cerevisiae. Mol. Cell. Biol. 15: 3767â€“3776.
    Biol. 12: 3460â€“3469.                                                     Ho, Y.,  Gruhler,  Heilburt, G. D. Bader, L. Moore et al., 2002
Dufour, J. P.,  Goffeau, 1978 Solubilization lysolecithin               Systematic identification protein complexes Saccharomyces
    purification plasma membrane ATPase yeast                  cerevisiae mass spectrometry. Nature 415: 180â€“183.
    Schizosaccharomyces pombe. J. Biol. Chem. 253: 7026â€“7032.                Hoffman, C. S., F. Winston, 1987 minute DNA prepara-
Egloff, M. P., D. F. Johnson, G. Moorhead, P. T. Cohen, P. Cohen                 tion yeast efficiently releases autonomous plasmids trans-
    et al., 1997 Structural basis recognition regulatory              formation Escherichia coli. Gene 57: 267â€“272.
    subunits catalytic subunit protein phosphatase 1. EMBO         Holcomb, C. L., W. J. Hansen, T. Etcheverry R. Schekman,
    J. 16: 1876â€“1887.                                                            1988 Secretory vesicles externalize major plasma membrane
Eraso, P.,  Cid R. Serrano, 1987 Tight control               ATPase yeast. J. Cell Biol. 106: 641â€“648.
 1436                                                T. Williams-Hart, X. Wu K. Tatchell
Huang, D.,  Farkas P. J. Roach, 1996 Pho85p, cyclin-depen-              Association transcription factor IIA TATA binding protein
    dent protein kinase, Snf1p protein kinase act antagonisti-          required transcriptional activation subset promoters
    cally control glycogen accumulation Saccharomyces cerevisiae.         cell cycle progression Saccharomyces cerevisiae. Mol. Cell.
    Mol. Cell. Biol. 16: 4357â€“4365.                                             Biol. 18: 2559â€“2570.
Huang, D., J. Moffat, W.  Wilson, L. Moore, C. Cheng et al.,              Perlin, D. S., C. L. Brown J. E. Haber, 1988 Membrane poten-
    1998 Cyclin partners determine Pho85 protein kinase substrate               tial defect hygromycin B-resistant pma1 mutants Saccharo-
    specificity vitro vivo: control glycogen biosynthesis          myces cerevisiae. J. Biol. Chem. 263: 18118â€“18122.
    Pcl8 Pcl10. Mol. Cell. Biol. 18: 3289â€“3299.                      Peters, C., P. D. Andrews, M. J. Stark, S. Cesaro-Tadic,  Glatz et
Kaiser, C., S. Michaelis  Mitchell, 1994 Methods Yeast                 al., 1999 Control terminal step intracellular membrane
    Genetics: Cold Spring Harbor Laboratory Course Manual. Cold               fusion protein phosphatase 1. Science 285: 1084â€“1087.
    Spring Harbor Laboratory Press, Plainview, NY.                          Portillo, F., P. Eraso R. Serrano, 1991 Analysis regula-
Kolarov, J., J. Kulpa, M. Baijot  Goffeau, 1988 Character-                tory domain yeast plasma membrane Hâ«¹-ATPase directed
    ization protein serine kinase yeast plasma membrane.              mutagenesis intragenic suppression. FEBS Lett. 287: 71â€“74.
    J. Biol. Chem. 263: 10613â€“10619.                                        Posas, F., M. Camps J. Arino, 1995 PPZ protein phospha-
Kotliar, N., C.  Stella, E. H. Ramos J. R. Mattoon, 1994                  tases important determinants salt tolerance yeast cells.
    L-leucine transport systems Saccharomyces cerevisiae participation       J. Biol. Chem. 270: 13036â€“13041.
    GAP1, S1 S2 transport systems. Cell Mol. Biol. 40: 833â€“842.      Ramaswamy, N. T., L. Li, M. Khalil J. F. Cannon, 1998 Regula-
Kuno, T., H. Tanaka, H. Mukai, C. D. Chang, K. Hiraga et al.,                   tion yeast glycogen metabolism sporulation Glc7p pro-
    1991 cDNA cloning calcineurin B homolog Saccharomyces               tein phosphatase. Genetics 149: 57â€“72.
    cerevisiae. Biochem. Biophys. Res. Commun. 180: 1159â€“1163.              Rao, R., C. W. Slayman, 1993 Mutagenesis conserved resi-
MacKelvie, S. H., P. D. Andrews M. J. R. Stark, 1995                    dues phosphorylation domain yeast plasma mem-
    Saccharomyces cerevisiae gene SDS22 encodes potential regulator           brane H(â«¹)-ATPase. Effects structure function. J. Biol.
    mitotic function yeast type 1 protein phosphatase. Mol.           Chem. 268: 6708â€“6713.
    Cell. Biol. 15: 3777â€“3785.                                              Rhodes, N., M. Company B. Errede, 1990 yeast-Escherichia
MacMillan, L. B., M.  Bass, N. Cheng, E. F. Howard, M. Tamura                 coli shuttle vector containing M13 origin replication. Plas-
    et al., 1999 Brain actin-associated protein phosphatase 1 holoen-           mid 23: 159â€“162.
    zymes containing spinophilin, neurabin, selected catalytic          Rose, M. D., P. Novick, J. H. Thomas, D. Botstein G. R. Fink,
    subunit isoforms. J. Biol. Chem. 274: 35845â€“35854.                          1987 Saccharomyces cerevisiae genomic plasmid bank based Madrid, R., M. J. Gomez, J. Ramos  Rodriguez-Navarro, 1998                centromere-containing shuttle vector. Gene 60: 237â€“243.
    Ectopic potassium uptake trk1 trk2 mutants Saccharomyces          Rudolph, H. K.,  Antebi, G. R. Fink, C. M. Buckley, T. E. Dorman
    cerevisiae correlates highly hyperpolarized membrane po-             et al., 1989 yeast secretory pathway perturbed muta-
    tential. J. Biol. Chem. 273: 14838â€“14844.                                   tions PMR1, member Ca2â«¹ ATPase family. Cell 58:
Matheos, D. P., T. J. Kingsbury, U. S. Ahsan K. W. Cunning-                 133â€“145.
    ham, 1997 Tcn1p/Crz1p, calcineurin-dependent transcrip-               Sassoon, , F. F. Severin, P. D. Andrews, M.-R. Taba, K. B. Kaplan
    tion factor differentially regulates gene expression Saccha-        et al., 1999 Regulation Saccharomyces cerevisiae kinetochores
    romyces cerevisiae. Genes Dev. 11: 3445â€“3458.                               type 1 phosphatase Glc7p. Genes Dev. 13: 545â€“555.
McCusker, J. H., J. E. Haber, 1988 Cycloheximide-resistant              Serrano, R., 1983a vivo glucose activation yeast plasma
    temperature-sensitive lethal mutations Saccharomyces cerevisiae.         membrane ATPase. FEBS Lett. 156: 11â€“14.
    Genetics 119: 303â€“315.                                                  Serrano, R., 1983b Purification reconstitution proton-
McCusker, J. H., D. S. Perlin J. E. Haber, 1987 Pleiotropic                 pumping ATPase fungal plant plasma membranes. Arch.
    plasma membrane ATPase mutations Saccharomyces cerevisiae.               Biochem. Biophys. 227: 1â€“8.
    Mol. Cell. Biol. 7: 4082â€“4088.
                                                                            Serrano, R., C. Montesinos, M. Roldan, G. Garrido, C. Ferguson
Mendoza, , F. Rubio,  Rodriguez-Navarro J. M. Pardo,
                                                                                et al., 1991 Domains yeast plasma membrane ATPase-
    1994 protein phosphatase calcineurin essential NaCl
                                                                                associated glycoprotein. Biochim. Biophys. Acta 1062: 157â€“164.
    tolerance Saccharomyces cerevisiae. J. Biol. Chem. 269: 8792â€“
                                                                            Serrano, R., J. M. Villalba, M. G. Palmgren, F. Portillo,  Parets-
    8796.
                                                                                Soler et al., 1992 Studies plasma membrane H(â«¹)-
Miller, J. H., 1972 Experiments Molecular Genetics. Cold Spring
                                                                                ATPase yeast plants. Biochem. Soc. Trans. 20: 562â€“566.
    Harbor Laboratory Press, Cold Spring Harbor, NY.
                                                                            Seto-Young, D., D. S. Perlin, 1991 Effect membrane voltage
Mulet, J. M., M. P. Leube, S. J. Kron, G. Rios, G. R. Fink et al., 1999
                                                                                plasma membrane H(â«¹)-ATPase Saccharomyces cerevisiae.
    novel mechanism ion homeostasis salt tolerance                                                                                 J. Biol. Chem. 266: 1383â€“1389.
    yeast: Hal4 Hal5 protein kinases modulate Trk1-Trk2
    potassium transporter. Mol. Cell. Biol. 19: 3328â€“3337.                  Shenolikar, S., 1994 Protein serine/threonine phosphatasesâ€”new
Mulkey, R. M., S. Endo, S. Shenolikar R. C. Malenka, 1994                   avenues cell regulation. Annu. Rev. Cell Biol. 10: 55â€“86.
    Involvement calcineurin/inhibitor-1 phosphatase cascade         Shenolikar, S.,  C. Nairn, 1991 Protein phosphatases: recent
    hippocampal long-term depression. Nature 369: 486â€“488.                      progress. Adv. Second Messenger Phosphoprotein Res. 23: 1â€“121.
Nakamoto, R. K., R. Rao C. W. Slayman, 1991 Expression               Sikorski, R. S., P. Hieter, 1989 shuttle vectors     yeast plasma membrane [Hâ«¹]ATPase secretory vesicles.                 yeast host strains designed efficient manipulation DNA     new strategy directed mutagenesis. J. Biol. Chem. 266:                Saccharomyces cerevisiae. Genetics 122: 19â€“27.
    7940â€“7949.                                                              Slayman, C. L., 1965a Electrical properties Neurospora crassa. Ef-
Nakamura, T., Y. Liu, D. Hirata, H. Namba, S. Harada et al., 1993               fects external cations intracellular potential. J. Gen.
    Protein phosphatase type 2B (calcineurin)-mediated, FK506-sen-              Physiol. 49: 69â€“92.
    sitive regulation intracellular ions yeast important        Slayman, C. L., 1965b Electrical properties Neurospora crassa.
    determinant adaptation high salt stress conditions. EMBO             Respiration intracellular potential. J. Gen. Physiol. 49:
    J. 12: 4063â€“4071.                                                           93â€“116.
Nass, R., K. W. Cunningham R. Rao, 1997 Intracellular seques-           Slayman, C. L., W. S. Long C. Y. Lu, 1973 relationship
    tration sodium novel Naâ«¹/Hâ«¹ exchanger yeast                   ATP electrogenic pump plasma membrane
    enhanced mutations plasma membrane Hâ«¹-ATPase.                     Neurospora crassa. J. Membr. Biol. 14: 305â€“338.
    Insights mechanisms sodium tolerance. J. Biol. Chem.            Smith, F. D., G. S. Oxford S. L. Milgram, 1999 Association
    272: 26145â€“26152.                                                           D2 dopamine receptor cytoplasmic loop Norbeck, J.,  Blomberg, 1998 Amino acid uptake strongly                spinophilin, protein phosphatase-1-interacting protein. J. Biol.
    affected exponential growth Saccharomyces cerevisiae           Chem. 274: 19894â€“19900.
    0.7 M NaCl medium. FEMS Microbiol. Lett. 158: 121â€“126.                  Stathopoulos,  M., M. S. Cyert, 1997 Calcineurin acts
Novoa, , H. Zeng, H. P. Harding D. Ron, 2001 Feedback                     CRZ1/TCN1-encoded transcription factor regulate
    inhibition unfolded protein response GADD34-medi-                 gene expression yeast. Genes Dev. 11: 3432â€“3444.
    ated dephosphorylation eIF2â?£. J. Cell Biol. 153: 1011â€“1021.          Stathopoulos-Gerontides, , J. J. Guo M. S. Cyert, 1999
Ozer, J., L. E. Lezina, J. Ewing, S. Audi P. M. Lieberman, 1998             Yeast calcineurin regulates nuclear localization Crz1p tran-
                                                           Glc7-Dependent Ion Transport                                                       1437
    scription factor dephosphorylation. Genes Dev. 13: 798â€“          Venturi, G. M.,  Bloecher, T. Williams-Hart K. Tatchell,
    803.                                                                         2000 Genetic interactions GLC7, PPZ1 PPZ2 Stuart, J. S., D. L. Frederick, C. M. Varner K. Tatchell, 1994               Saccharomyces cerevisiae. Geneti